Moreover, SEMA6B gene mutations are a leading factor in the development of SEMA6B-related progressive myoclonic epilepsy (PME-11) [38,39,85,86,87,88,89]. This evidence concerns the gene SEMA6B and Progressive myoclonic epilepsy.